Search research articles
Contact Us
Filters
Showing results (1-10 of 69) with videos related to
Page
of 7
Sort By:
Nature Reviews. Gastroenterology & Hepatology
|
December 5, 2024
The steatotic liver disease burden paradox: unravelling the key role of alcohol
Nikolaj Torp, Mads Israelsen, Aleksander Krag
Hepatology (Baltimore, Md.)
|
February 17, 2025
Letter to the Editor: Alcohol a confounding factor in the assessment of resmetirom therapy
Aleksander Krag, Nikolaj Torp, Mads Israelsen
The Lancet. Gastroenterology & Hepatology
|
April 11, 2024
Validating the new nomenclature of steatotic liver disease in patients with excessive alcohol intake - Authors' reply
Mads Israelsen, Mary E Rinella, Aleksander Krag
Hepatology Communications
|
October 11, 2024
Transforming steatotic liver disease management: The emerging role of GLP-1 receptor agonists
Ellen L Jensen, Mads Israelsen, Aleksander Krag
Alimentary Pharmacology & Therapeutics
|
December 17, 2020
Editorial: can quantitative fibrosis assessment be used to enhance prediction of outcomes in patients with alcohol-related liver disease? Authors' reply
Mads Israelsen, Marta Guerrero Misas, Emmanuel A Tsochatzis
The Lancet. Gastroenterology & Hepatology
|
March 14, 2026
Developing policy for steatotic liver disease: an even better buy?
Oliver D Tavabie, Megan E Rawcliffe, Mads Israelsen
Alimentary Pharmacology & Therapeutics
|
May 21, 2026
Editorial: Two Common Risks, One Greater Harm-Diabetes and Alcohol in Steatotic Liver Disease
Stine Johansen, Nikolaj Torp, Mads Israelsen, et al.
Alimentary Pharmacology & Therapeutics
|
August 23, 2025
Editorial: Implementing Risk Assessment Tools for MetALD in Clinical Practice-Authors' Reply
Nikolaj Torp, Mads Israelsen, Stine Johansen, et al.
Gastroenterology
|
May 30, 2026
Reply to Ou and Xu and to Chang and Mao
Nikolaj Torp, Stine Johansen, Mads Israelsen, et al.
Seminars in Liver Disease
|
June 9, 2025
MetALD: Genetic Factors and Clinical Outcomes
Mads Israelsen, Eric Trépo, Aleksander Krag, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 69) with videos related to
Sort By:
Page
of 7
Nature Reviews. Gastroenterology & Hepatology
|
December 5, 2024
The steatotic liver disease burden paradox: unravelling the key role of alcohol
Nikolaj Torp, Mads Israelsen, Aleksander Krag
Hepatology (Baltimore, Md.)
|
February 17, 2025
Letter to the Editor: Alcohol a confounding factor in the assessment of resmetirom therapy
Aleksander Krag, Nikolaj Torp, Mads Israelsen
The Lancet. Gastroenterology & Hepatology
|
April 11, 2024
Validating the new nomenclature of steatotic liver disease in patients with excessive alcohol intake - Authors' reply
Mads Israelsen, Mary E Rinella, Aleksander Krag
Hepatology Communications
|
October 11, 2024
Transforming steatotic liver disease management: The emerging role of GLP-1 receptor agonists
Ellen L Jensen, Mads Israelsen, Aleksander Krag
Alimentary Pharmacology & Therapeutics
|
December 17, 2020
Editorial: can quantitative fibrosis assessment be used to enhance prediction of outcomes in patients with alcohol-related liver disease? Authors' reply
Mads Israelsen, Marta Guerrero Misas, Emmanuel A Tsochatzis
The Lancet. Gastroenterology & Hepatology
|
March 14, 2026
Developing policy for steatotic liver disease: an even better buy?
Oliver D Tavabie, Megan E Rawcliffe, Mads Israelsen
Alimentary Pharmacology & Therapeutics
|
May 21, 2026
Editorial: Two Common Risks, One Greater Harm-Diabetes and Alcohol in Steatotic Liver Disease
Stine Johansen, Nikolaj Torp, Mads Israelsen, et al.
Alimentary Pharmacology & Therapeutics
|
August 23, 2025
Editorial: Implementing Risk Assessment Tools for MetALD in Clinical Practice-Authors' Reply
Nikolaj Torp, Mads Israelsen, Stine Johansen, et al.
Gastroenterology
|
May 30, 2026
Reply to Ou and Xu and to Chang and Mao
Nikolaj Torp, Stine Johansen, Mads Israelsen, et al.
Seminars in Liver Disease
|
June 9, 2025
MetALD: Genetic Factors and Clinical Outcomes
Mads Israelsen, Eric Trépo, Aleksander Krag, et al.
Page
of 7